Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector




















Sort by: Date|Relevance

FDA Accepts NDA for Global Blood Therapeutics' Sickle Cell Drug; Shares Up 14%

Shares of Global Blood Therapeutics are trading more than 14% higher after the FDA accepted its New Drug Application filing for Voxelotor, a drug used in the treatment of sickle cell disease. Earlier today clinical-stage biopharmaceutical firm Global Blood Therapeuti...

What Do These Three Charts Have in Common?

Bob Moriarty of 321gold provides three charts for readers. Hint: That's what massive tops look like. Don't tell anyone else, I want to keep it a secret between you and me. Bob Moriarty founded 321gold.com , with his late wife, Barbara Moriarty, more...

Gold Could Be Trending Higher Against the Dow

The Dow/Gold ratio broke a trend-line in past few weeks that could be signaling that gold could be trending higher against the Dow Jones Industrial Index in the next 18 months to two years. An example might be a ratio of 10 or the Dow at 20,000 and gold at $2,000 (a new...

A Historical Perspective on Silver

When we don't understand the present, we can turn to the past. It is believed the natural ratio in the earth's crust is ~10 ounces of silver for one ounce of gold. Back in 3000 BC in Mesopotamia (modern day Turkey, Iraq, Iran), silver and gold were used to enable trade ...

Gold Is Due a Correction

All markets go up. All markets go down. No market ever goes straight up unless it's the end of the world and in that case why would you care? Gold hit bottom in early 2016. Smart money was buying then. Gradually gold rose and fell with the tide until lately when it we...

Q2 Earnings Beat Boosts Caleres Stock 24%, But Is There Room to Run in This Rally?

Investors responded favorably to this footwear stock's Q2/19 results, elevating the stock price 24% on Tuesday. However, the stock is still down quite a bit from its 6-month and 1-year highs. Footwear company Caleres Inc. (CAL:NYSE) reported an assortment of positiv...

Energy Firm Reacts to Oil Price Weakening with 2019 Budget Decrease

The company's revised estimates, the reasons for and repercussions of them are addressed in a CIBC report. In an Aug. 26 research note, analyst Dave Popowich reported that his firm CIBC reduced its price target on Whitecap Resources Inc. (WCP:TSX) to CA$7.25 per sha...

Silver, Gold and Platinum Are Due a Break

When you are climbing the steepest of mountains, especially at high altitudes, it can be tiring. If you start getting a nosebleed, you are simply working too hard and need a break. The DSI (Daily Sentiment Index) on gold hit 97 four weeks ago and while it has struggled ...

Silver's Sharp Reaction Back

Technical analyst Clive Maund charts silver and explains why he believes it hasn't hit a final top. Silver reacted back sharply on Thursday and Friday after a parabolic blowoff top. This was not a final top, but it does indicate that silver needs to take a rest and co...

T2 Biosystems Receives BARDA Contract to Fight Antimicrobial Resistance, Shares Up More than 88%

This healthcare diagnostics stock rose more than 88% on Wednesday following the award of a BARDA contract that could be worth up to $69 million. On Wednesday morning, T2 BioSystems Inc. (TTOO:NASDAQ) announced receipt of funding from the U.S. Department of Health a...
1 2 3 4 5 6 7 8 9 10 ...